# | Drug | Count |
---|---|---|
0 | PEGFILGRASTIM | 5495 |
1 | ADALIMUMAB | 3492 |
2 | INSULIN GLARGINE | 2542 |
3 | ABATACEPT | 2522 |
4 | GOLIMUMAB | 2399 |
5 | ALBUTEROL SULFATE | 2241 |
6 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 2178 |
7 | EXENATIDE | 2152 |
8 | SECUKINUMAB | 1679 |
9 | MOMETASONE FUROATE | 1380 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | ACLIDINIUM BROMIDE | 1275 | 0.2287 |
1 | NITRIC OXIDE | 466 | 0.1794 |
2 | CICLOPIROX OLAMINE | 67 | 0.1111 |
3 | BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE | 52 | 0.1106 |
4 | LONAPEGSOMATROPIN-TCGD | 16 | 0.1103 |
5 | BECLOMETHASONE DIPROPIONATE HFA | 204 | 0.1079 |
6 | TESTOSTERONE GEL, 1% | 14 | 0.1069 |
7 | GLYCOPYRROLATE AND FORMOTEROL FUMARATE | 135 | 0.0930 |
8 | PEGFILGRASTIM | 5495 | 0.0668 |
9 | GUSELKUMAB | 873 | 0.0573 |
# | Drug class | Count |
---|---|---|
0 | Leukocyte Growth Factor [EPC] | 5511 |
1 | Corticosteroid [EPC] | 3972 |
2 | Tumor Necrosis Factor Blocker [EPC] | 3702 |
3 | Insulin Analog [EPC] | 3551 |
4 | GLP-1 Receptor Agonist [EPC] | 2833 |
5 | Selective T Cell Costimulation Modulator [EPC] | 2522 |
6 | Interleukin-17A Antagonist [EPC] | 1751 |
7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1693 |
8 | Interleukin-23 Antagonist [EPC] | 1418 |
9 | Folate Analog Metabolic Inhibitor [EPC] | 1319 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Leukocyte Growth Factor [EPC] | 5511 | 0.0482 |
1 | Selective T Cell Costimulation Modulator [EPC] | 2522 | 0.0238 |
2 | Gonadotropin [EPC] | 25 | 0.0178 |
3 | Recombinant Human Growth Hormone [EPC] | 213 | 0.0163 |
4 | GLP-1 Receptor Agonist [EPC] | 2833 | 0.0138 |
5 | Interleukin-23 Antagonist [EPC] | 1418 | 0.0119 |
6 | Interleukin-17A Antagonist [EPC] | 1751 | 0.0119 |
7 | Medium-chain Triglyceride [EPC] | 3 | 0.0114 |
8 | Insulin Analog [EPC] | 3551 | 0.0093 |
9 | Parathyroid Hormone [EPC] | 37 | 0.0084 |